Company Performance: 4D Nanoscope's financial health and growth prospects are crucial. Revenue, earnings, and pipeline progress impact investor confidence.

Market Sentiment: Overall investor optimism or pessimism, particularly towards biotech companies, influences stock prices.

Clinical Trial Results: Positive clinical trial data for 4D Nanoscope's gene therapy candidates typically drives up the stock price, while negative results can lead to a decline.

Regulatory Approvals: FDA approvals or rejections significantly affect the perceived value of 4D Nanoscope's products and future revenue potential.

Competition: The presence and success of competing gene therapy companies or alternative treatments impact 4D Nanoscope's market share and attractiveness to investors.

Economic Conditions: Broad economic factors, such as interest rates and inflation, can influence investment decisions and overall stock market performance, affecting 4DN.STU.

Partnerships & Collaborations: Strategic alliances or partnerships with other companies can signal strength and expand 4D Nanoscope's reach, positively affecting the stock price.

News & Events: Company-specific news, industry events, and analyst ratings can create short-term volatility in the stock price.

Shareholder Actions: Significant stock purchases or sales by institutional investors or company insiders can influence supply and demand, impacting the price.